NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02080221,BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial,https://clinicaltrials.gov/study/NCT02080221,,COMPLETED,"A standard treatment for your cancer is called FOLFIRINOX (this utilizes the FDA approved chemotherapy drugs fluorouracil, leucovorin, oxaliplatin and irinotecan). In this study you will receive the chemotherapy treatment FOLFOX-A (fluorouracil, oxaliplatin, leucovorin and Abraxane ®) which substitutes irinotecan for the FDA approved chemotherapy drug Abraxane ®. Even though Abraxane is FDA approved for pancreatic cancer, the combination of Abraxane with the other 3 drugs is being investigated. Your doctors are studying the activity and side effects of FOLFOX-A in advanced (metastatic) pancreatic cancer.",YES,Metastatic Pancreatic Cancer,DRUG: FOLFOXA,"Survival for Patients With Metastatic Pancreatic Cancer With First-line Treatment With FOLFOX-A as Compared to Historical Controls of Gemcitabine Alone., Every 3 months for up to 5 years","Response of Patients With Metastatic Pancreatic Cancer Who Receive the FOLFOX-A Regimen, Every 3 months for up to 5 years.",,Brown University,Lifespan|SouthCoast Medical Group|Memorial hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,BrUOG 292,2014-08,2020-01-09,2022-03-16,2014-03-06,2021-03-11,2022-08-01,"Southcoast centers for cancer care, Fairhaven, Massachusetts, 02179, United States|Lifespan Hospitals (The Miriam and RI Hospital, East Greenwich, Newport), Providence, Rhode Island, 02903, United States","Study Protocol, Statistical Analysis Plan, and Informed Consent Form, https://storage.googleapis.com/ctgov2-large-docs/21/NCT02080221/Prot_SAP_ICF_000.pdf"
